|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Elevation Oncology, Inc. (ELEV) |
|
|
$0.37 0.00 (1.32%) as of 4:30 Mon 6/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
59,110,000 |
Market
Cap: |
21.70(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.233 - $3.02 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Co.'s primary drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1, a type of genomic alteration and oncogenic driver, and other receptor tyrosine-protein kinase erbB- (HER3), genomically defined cancers. Co. is also evaluating opportunities for pipeline expansion including prioritizing additional targeted therapy approaches in tumor types defined by genomic driver alterations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-06-16 |
4 |
D |
$0.39 |
$1,783 |
D/D |
(4,627) |
145,085 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,560 |
149,712 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2025-05-15 |
4 |
D |
$0.30 |
$235 |
D/D |
(784) |
10,075 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2025-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,643 |
10,859 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-05-15 |
4 |
D |
$0.30 |
$690 |
D/D |
(2,303) |
137,152 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
139,455 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-03-16 |
4 |
D |
$0.53 |
$2,466 |
D/D |
(4,628) |
133,205 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
137,833 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-02-15 |
4 |
D |
$0.67 |
$6,187 |
D/D |
(9,211) |
125,271 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2025-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
134,482 |
|
- |
|
Jansen Valerie Malyvanh |
CHIEF MEDICAL OFFICER |
|
2025-02-15 |
4 |
D |
$0.67 |
$3,485 |
D/D |
(5,189) |
12,311 |
|
- |
|
Jansen Valerie Malyvanh |
CHIEF MEDICAL OFFICER |
|
2025-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
|
- |
|
Dornan David |
CHIEF SCIENTIFIC OFFICER |
|
2025-02-15 |
4 |
D |
$0.67 |
$2,789 |
D/D |
(4,152) |
5,223 |
|
- |
|
Dornan David |
CHIEF SCIENTIFIC OFFICER |
|
2025-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
9,375 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2025-02-15 |
4 |
D |
$0.67 |
$1,927 |
D/D |
(2,869) |
8,216 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2025-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,675 |
8,305 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2024-12-16 |
4 |
D |
$0.64 |
$2,963 |
D/D |
(4,629) |
109,482 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2024-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,563 |
114,111 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2024-11-15 |
4 |
D |
$0.53 |
$52 |
D/D |
(98) |
1,410 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2024-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
1,508 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2024-09-16 |
4 |
D |
$0.61 |
$2,823 |
D/D |
(4,628) |
101,548 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2024-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,562 |
106,176 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2024-08-15 |
4 |
D |
$0.72 |
$64 |
D/D |
(89) |
1,208 |
|
- |
|
Furlong Tammy |
CHIEF FINANCIAL OFFICER |
|
2024-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
1,297 |
|
- |
|
Ferra Joseph J Jr |
CHIEF EXECUTIVE OFFICER |
|
2024-06-16 |
4 |
D |
$3.23 |
$14,948 |
D/D |
(4,628) |
93,614 |
|
- |
|
61 Records found
|
|
Page 1 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|